Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

Clinical trial NCT07535710 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07535710
Sponsor: Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma Refractory Cutaneous T-Cell Lymphoma, Relapsed Sezary Syndrome Cutaneous T Cell Lymphoma (CTCL)

Start date: 2026-03-30
Primary completion: 2027-12-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.